Invenomic FundBIVRX
Type
Mutual fund
Peer group
Alternative
Net assets
$970.1M
Expense ratio
3.30%
1-year return
-0.4%
3 years, a year
-3.3%
5 years, a year
+12.8%
Holdings
279
What it aims to do.
The investment objective of the Invenomic Fund (the ?Fund?) is to seek long term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| First American Funds Inc | 7.12% |
| LYFT Lyft Inc | 3.15% |
| WDAY Workday Inc | 3.11% |
| FISV Fiserv Inc | 3.06% |
| CRM Salesforce Inc | 3.00% |
| GPN Global Payments Inc | 2.88% |
| FIS Fidelity National Information Services Inc | 2.33% |
| INGR Ingredion Inc | 2.10% |
| XRAY Dentsply Sirona Inc | 2.09% |
| PENN Penn Entertainment Inc | 2.01% |
More on BIVRX.
- BIVRX overview
- BIVRX holdings
- BIVRX risk
- BIVRX costs
- BIVRX money in and out
- BIVRX share classes
- Compare BIVRX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.